BCR-ABL physically interacts with β-catenin and stabilizes and stimulates β-catenin through activation of phosphoinositide 3 kinase (PI3K)/Akt signaling in BP-CML cells. The gene discussed is AKT1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.